| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/13/2003 | US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032061 Nucleotide sequences coding polypeptide for use in the treatment of inflammation, tumors and immunological and inflammatory bowel disease |
| 02/13/2003 | US20030032060 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032032 Diagnosing viral brain disorders; obtain sample nucleic acids, incubate with marker probe, denature, hybridize, detect signal from probe, presence of signal indicates viral infection |
| 02/13/2003 | US20030032031 Diagnosing liver defects in humans; obtain fluid sample, determine concentration of viral core protein present, evaluate for liver defects |
| 02/13/2003 | US20030032023 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 02/13/2003 | US20030032009 09007761method for influencing the p53 linkage to target genes |
| 02/13/2003 | US20030032005 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 02/13/2003 | US20030031682 Pathogens useful as vaccines for therapy and/ or prophylaxis |
| 02/13/2003 | US20030031675 For the immunomodulation of a human or animal; decreasing T-cell proliferation |
| 02/13/2003 | US20030031673 Treatment and diagnosis of cancer |
| 02/13/2003 | US20030031672 Individualized anti-cancer antibodies |
| 02/13/2003 | US20030031670 Diagnosis and treatment of malignant neoplasms |
| 02/13/2003 | US20030031669 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 02/13/2003 | US20030031668 Treatment of immune complex disease with anti-CD40L antibodies |
| 02/13/2003 | US20030031667 Human monoclonal antibodies to dendritic cells |
| 02/13/2003 | US20030031665 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 02/13/2003 | US20030031664 For therapy of pulmonary embolism, myocardial infarction, thrombosis or stroke |
| 02/13/2003 | US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses |
| 02/13/2003 | US20030031653 Compositions and methods for eliciting immune responses with a secretion-directed protein |
| 02/13/2003 | US20030031627 For diagnosis and therapy |
| 02/13/2003 | CA2838062A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2808598A1 Antigenic polypeptides |
| 02/13/2003 | CA2456229A1 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | CA2456105A1 Modular assembly of nucleic acid-protein fusion multimers |
| 02/13/2003 | CA2455877A1 Apparatus and method for determining the onset and presence of sepsis conditions |
| 02/13/2003 | CA2455365A1 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | CA2455237A1 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | CA2455194A1 Vascular endothelial growth factor isoform having anti-angiogenic activity |
| 02/13/2003 | CA2455154A1 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | CA2453939A1 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 02/13/2003 | CA2453937A1 Antigenic polypeptides |
| 02/13/2003 | CA2407299A1 Peptide sequence tags and method of using same |
| 02/12/2003 | EP1283268A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283255A1 Myocardial cell proliferation-associated genes |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1283215A2 Secreted polypeptide and nucleic acids encoding it |
| 02/12/2003 | EP1283059A2 Therapeutic conjugates of toxins and drugs |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283053A1 Inhibitors of HER3 activity |
| 02/12/2003 | EP1282822A2 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen |
| 02/12/2003 | EP1282722A1 Stabilized proteins |
| 02/12/2003 | EP1282714A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282703A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 02/12/2003 | EP1282700A1 Neuronal serine-threonine protein kinase |
| 02/12/2003 | EP1282696A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 02/12/2003 | EP1282692A2 Sentinel virus ii |
| 02/12/2003 | EP1282646A2 Human monoclonal antibodies to dendritic cells |
| 02/12/2003 | EP1282642A2 Therapeutic pore-forming peptides |
| 02/12/2003 | EP1282636A2 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 02/12/2003 | EP1282444A1 Antithrombotic agents |
| 02/12/2003 | EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 02/12/2003 | EP1282442A1 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 02/12/2003 | EP1282441A2 Treating t-cell mediated diseases by modulating dr6 activity |
| 02/12/2003 | EP1282440A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumor agents |
| 02/12/2003 | EP1282421A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 02/12/2003 | CN1396832A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 02/12/2003 | CN1396454A Process for preparing cross-linking antibody by solid-phase immunoadsorption method |
| 02/12/2003 | CN1396261A Human growth and differentiation factor 7 and its coding sequence preparing process and application |
| 02/12/2003 | CN1396260A Ox bLATS1 gene, nucleotide, protein coding sequence and its preparing process and application |
| 02/12/2003 | CN1396259A Chicken cLATS1 gene, nucleoside, proteincoding sequence and its preparing process and application |
| 02/12/2003 | CN1396183A Human fusion antibody for reducing cerebral amyloid fibers associated with senile dementia |
| 02/12/2003 | CN1396182A Human monoclonal antibody of human endophloeodal growth factor receptor 2 protein and its preparing process |
| 02/12/2003 | CN1396181A Monoclonal antibody and its preparing process and usage |
| 02/12/2003 | CN1396178A Engineered polypeptide resisting infection of coated virus (hepatitis B virus) and its preparing process |
| 02/12/2003 | CN1101404C Anti Bacillus pyocyaneu vitelline immunoglobulin products and use thereof |
| 02/11/2003 | WO2002014871A1 Method of detecting or assaying hbv |
| 02/11/2003 | US6518415 Recombinant human anti-Lewis Y antibodies |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518065 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518031 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/11/2003 | US6518016 Screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C (APC). The method is directed at detecting one or more mutations at one or more of the cleavage and/or binding |
| 02/11/2003 | US6517845 Detecting infection in a mammal; binding antibody to polypeptide consisting essentially of amino acid sequence 2 |
| 02/11/2003 | US6517835 Growth differentiation factor-11 |
| 02/11/2003 | US6517829 Cells having expressed and immobilised at their outer surface active heavy chain antibodies from an animal in the family Camelidae |
| 02/11/2003 | US6517203 System, apparatus, and method for correcting vision using electro-active spectacles |
| 02/11/2003 | CA2231409C Antibodies specific for native prpsc |
| 02/11/2003 | CA2170509C Dna encoding prostaglandin receptor ep2 |
| 02/11/2003 | CA2152667C Bone resorption assay |
| 02/11/2003 | CA2141554C Morphogen-induced nerve regeneration and repair |
| 02/11/2003 | CA2133843C Melanocyte stimulating hormone receptor and uses |
| 02/11/2003 | CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region |
| 02/06/2003 | WO2003010542A1 Cancer diagnostics |
| 02/06/2003 | WO2003010539A1 Method and means for detecting alcohol consumption |
| 02/06/2003 | WO2003010317A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | WO2003010316A1 Bacteriophage-mediated lysis anthrax bacteria |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010310A1 Method of examining allergic disease |
| 02/06/2003 | WO2003010291A2 Treatment of immune disorders and b cell disorders |
| 02/06/2003 | WO2003010282A2 Interleukin-1 beta antibodies |
| 02/06/2003 | WO2003010202A1 Concatameric immunoadhesion |
| 02/06/2003 | WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof |